NKX2-5 is a cardiac-specific transcription factor essential for heart development and function. It serves as a primary regulator of cardiac gene expression, including direct transcriptional activation of cardiomyocyte-specific genes such as LIPTER, which is crucial for lipid metabolism in human cardiomyocytes 1. NKX2-5 functions through DNA binding and protein-protein interactions, working synergistically with co-factors like MEF2 to regulate sarcomere proteins such as titin, where it binds to intronic enhancer elements essential for proper sarcomere formation and cardiac contractility 2. The transcription factor is expressed specifically in cardiomyocytes and cardiovascular progenitors, making it a valuable marker for cardiac cell lineages 3. Loss-of-function mutations in NKX2-5 cause severe cardiac malformations reminiscent of congenital heart defects observed in mouse models 4. Variants of unknown significance, such as K158N, demonstrate pathogenic potential through impaired DNA binding and reduced co-factor interactions 5. Clinically, NKX2-5 polymorphisms are associated with increased susceptibility to congenital heart disease 6. Beyond cardiac development, NKX2-5 may contribute to pathological processes in non-cardiac tissues through epigenetic regulation mechanisms 7.